Register Cart 0

Generic placeholder image

Current Traditional Medicine

Editor-in-Chief

ISSN (Print): 2215-0838
ISSN (Online): 2215-0846

Back Subscribe

Biography

Meet Our Associate Editor

Author(s): Hou-Wen Lin

Volume 5, Issue 1, 2019

Page: [1 - 2] Pages: 2

DOI: 10.2174/221508380501190603114331

Rights & Permissions Print Cite

Article Metrics

18

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Inhibition of Angiogenesis by Non-Steroidal Anti-Inflammatory Drugs: From the Bench to the Bedside and Back
Current Drug Targets - Inflammation & Allergy

Lipid-based Nanocarriers Loaded with Taxanes for the Management of Breast Cancer: Promises and Challenges
Current Drug Targets

Biomedical Applications of Accelerator Mass Spectrometry
Current Analytical Chemistry

Reducing radiation in chronic total occlusion percutaneous coronary interventions
Current Cardiology Reviews

Crosstalk Between The Immune Receptors and Gut Microbiota
Current Protein & Peptide Science

Targeting miR-21 Induces Autophagy and Chemosensitivity of Leukemia Cells
Current Drug Targets

Metalloprotein Inhibitors for the Treatment of Human Diseases
Current Topics in Medicinal Chemistry

Chaperoning the Cancer: The Proteostatic Functions of the Heat Shock Proteins in Cancer
Recent Patents on Anti-Cancer Drug Discovery

B Cell Depletion in Systemic Vasculitis
Current Immunology Reviews (Discontinued)

Cdc42 Signaling Pathway Inhibition as a Therapeutic Target in Ras- Related Cancers
Current Medicinal Chemistry

Current and Potential Treatments for Cervical Cancer
Current Cancer Drug Targets

Chelating Agents for the Treatment of Systemic Iron Overload
Current Medicinal Chemistry

Role of Angiogenesis Inhibitors in Colorectal Cancer: Sensitive and Insensitive Tumors
Current Cancer Drug Targets

Carbon Nanotubes in the Treatment of Skin Cancers: Safety and Toxic ological Aspects
Pharmaceutical Nanotechnology

6-Bromo-2,3-Dioxoindolin Phenylacetamide Derivatives: Synthesis, Potent CDC25B, PTP1B Inhibitors and Anticancer Activity
Letters in Drug Design & Discovery

Vasopressin in Health and Disease with a Focus on Affective Disorders
Central Nervous System Agents in Medicinal Chemistry

Defining Pharmacokinetics for Individual Patient Dosimetry in Routine Radiopeptide and Radioimmunotherapy of Cancer: Australian Experience
Current Pharmaceutical Design

Is Fibroblast Growth Factor Receptor 4 a Suitable Target of Cancer Therapy?
Current Pharmaceutical Design

Editorial (Thematic Issue: Gene Therapy for Gastrointestinal and Liver Cancers: Past Experience, Current Status and Future Perspectives)
Current Gene Therapy

Reduction in Ischemic Cerebral Infarction is Mediated through Golgi Phosphoprotein 3 and Akt/mTOR Signaling Following Salvianolate Administration
Current Neurovascular Research

© 2024 Bentham Science Publishers | Privacy Policy